ストックスクリーナーアプリを入手
1.23
1.60%
-0.02
アフターアワーズ：
1.24
0.01
+0.81%
前日終値:
$1.25
開ける：
$1.25
24時間の取引高:
50,986
Relative Volume:
0.27
時価総額：
$18.21M
収益：
-
当期純損益:
$-43.10M
株価収益率:
-0.1981
EPS:
-6.2098
ネットキャッシュフロー:
$-26.38M
1週間 パフォーマンス:
-1.60%
1か月 パフォーマンス:
-32.42%
6か月 パフォーマンス:
-17.45%
1年 パフォーマンス:
-64.35%
1日の値動き範囲:
$1.22
$1.26
1週間の範囲:
$1.22
$1.31
52週間の値動き範囲:
$1.20
$6.115
Tempest Therapeutics Inc Stock (TPST) Company Profile
名前
Tempest Therapeutics Inc
セクター
電話
415-798-8589
住所
2000 SIERRA POINT PARKWAY, BRISBANE
Compare TPST vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TPST
Tempest Therapeutics Inc
|
1.23 | 18.21M | 0 | -43.10M | -26.38M | -6.2098 |
VRTX
Vertex Pharmaceuticals Inc
|
451.63 | 114.63B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
609.94 | 63.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.72 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.09 | 37.13B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
162.99 | 34.65B | 742.00K | -1.37B | -1.07B | -7.0731 |
Tempest Therapeutics Inc Stock (TPST) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-22 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2025-04-10 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2025-04-10 | ダウングレード | Scotiabank | Sector Outperform → Sector Perform |
| 2024-03-14 | 開始されました | Scotiabank | Sector Outperform |
| 2024-02-08 | 開始されました | Jefferies | Buy |
Tempest Therapeutics Inc (TPST) 最新ニュース
Tempest Therapeutics Inc (TPST) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Tempest Therapeutics Inc (TPST) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Tempest Therapeutics Inc (TPST) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Tempest Therapeutics Inc (TPST) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Director at Tempest Therapeutics (TPST) receives 25,000 stock options grant - Stock Titan
[Form 3] Tempest Therapeutics, Inc. Initial Statement of Beneficial Ownership - Stock Titan
Tempest Therapeutics (TPST) Climbs 2.8% as Stock Approaches Critical $1.34 Resistance LevelLow Risk Entry Stocks - newsline.com
Tempest Therapeutics Inc (TPST) Valuation: PE, PB & Fair Value Analysis - TradingKey
Tempest Therapeutics Inc (TPST) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Tempest Therapeutics Inc (TPST) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Tempest Therapeutics Inc (TPST) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Tempest Therapeutics (TPST) Edges Higher as Stock Tests Resistance Near $1.34EMA Signal - newsline.com
Director Richey William Drake reports 2,000 TPST shares on Form 3 - Stock Titan
Tempest Therapeutics (TPST) director awarded 25,000 stock options at $1.27 strike - Stock Titan
Warrant share approvals on ballot at Tempest Therapeutics (NASDAQ: TPST) - Stock Titan
Tempest Therapeutics Announces CFO Transition and Board Changes - TipRanks
Tempest Therapeutics appoints two directors to board - Investing.com UK
Tempest Therapeutics appoints two directors to board By Investing.com - Investing.com South Africa
Tempest Therapeutics (NASDAQ: TPST) CFO to depart while two independent directors join board - Stock Titan
Tempest Therapeutics, Inc. Announces Executive Changes, Effective June 5, 2026 - marketscreener.com
Tempest Therapeutics Appoints Drake Richey and John Yee, MD, MPH to Board of Directors - GlobeNewswire
Tempest Therapeutics Executes Warrant-Inducement Equity Financing Deal - The Globe and Mail
Tempest Therapeutics Raises $2.0M via Warrant Exercise, Issues New and Placement Agent Warrants - TradingView
Tempest Therapeutics Announces Warrant Exercise for Approximately $2 Million in Gross Proceeds - 富途牛牛
TEMPEST THERAPEUTICS INC WT EXP Company Profile & Introduction - Moomoo
Tempest Therapeutics (TPST) inks $2M warrant exercise and new warrant deal - Stock Titan
Tempest Therapeutics, Inc. Files 8-K SEC Report Detailing Company Information and Stock Listing on NASDAQ - Minichart
Tempest Therapeutics Announces Resignation of Board Director - TipRanks
Tempest Therapeutics (TPST) asks shareholders to approve warrants convertible into millions of shares - Stock Titan
Tempest Therapeutics (TPST) director Simantov resigns and waives unpaid fees - Stock Titan
TPST Q1 2026 Earnings: Significant EPS Miss and No Revenue Reflect Pre-Revenue Stage PressuresNegative Surprise Momentum - The Legal Advocate
Tempest Therapeutics Q1 2026 Earnings: Wider-than-Expected Loss Amid Pre-Revenue Development StageEPS Surprise History - The Legal Advocate
Tempest Therapeutics secures $2M from warrant exercise By Investing.com - Investing.com Nigeria
Tempest Therapeutics secures $2M from warrant exercise - Investing.com
Tempest Therapeutics Announces Agreement for Warrant Exercise and New Short-Term Warrants - Quiver Quantitative
Tempest Therapeutics (TPST) Slumps 10%: Support Levels Under ScrutinyNegative Gamma - newsline.com
Tempest Therapeutics Inc. (TPST) Q1 2026 Earnings: Significant EPS Miss with No Revenue; Stock Edges UpInterim Report - Newser
Tempest Therapeutics announces resignation of three board members By Investing.com - Investing.com India
Tempest Therapeutics stock falls after $4.25 million direct offering - MSN
Tempest Therapeutics, Inc. Files Form 8-K with SEC – Company Information and Security Details (May 22, 2026) - Minichart
Tempest Therapeutics, Inc. 8-K Filing Details and Entity Information for May 19, 2026 - Minichart
Tempest Therapeutics (TPST) Edges Higher as Biotech Sector Shows Renewed InterestDiamond Pattern - Newser
Tempest Therapeutics announces resignation of three board members - Investing.com
Tempest Therapeutics Faces Nasdaq Listing and Governance Risks - TipRanks
Tempest Therapeutics Announces Multiple Board Director Resignations - TipRanks
Tempest Therapeutics receives Nasdaq notice for listing deficiencies - Investing.com UK
Tempest Therapeutics receives Nasdaq notice for listing deficiencies By Investing.com - Investing.com South Africa
Nasdaq flags Tempest Therapeutics (NASDAQ: TPST) on equity and board gaps - Stock Titan
[8-K] Tempest Therapeutics, Inc. Reports Material Event - Stock Titan
TPST Q1 2026 Earnings: Deep EPS Miss Highlights Clinical-Stage Biotech ChallengesNext Quarter Guidance - The Legal Advocate
Tempest Therapeutics Inc (TPST) 財務データ
収益
当期純利益
現金流量
EPS
0.74%
1.44%
大文字化:
|
ボリューム (24 時間):